In vitro antifungal activity of silver nanoparticles against fluconazole-resistant Candida species
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In vitro antifungal activity of silver nanoparticles against fluconazole-resistant Candida species
Authors
Keywords
Antimicrobial, <em class=EmphasisTypeItalic >Candida krusei</em>, <em class=EmphasisTypeItalic >Candida glabrata</em>, Cytotoxicity, Silver nanoparticles
Journal
WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY
Volume 31, Issue 11, Pages 1801-1809
Publisher
Springer Nature
Online
2015-09-02
DOI
10.1007/s11274-015-1933-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ANTIFUNGAL ACTIVITY OF SILVER NANOPARTICLES OBTAINED BY GREEN SYNTHESIS
- (2015) Eduardo José J. MALLMANN et al. REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
- Synthesis; characterization and antimicrobial effects of composites based on multi-substituted hydroxyapatite and silver nanoparticles
- (2014) Aurora Mocanu et al. APPLIED SURFACE SCIENCE
- The impact of new epidemiological cutoff values on Candida glabrata resistance rates and concordance between testing methods
- (2014) Ronen Ben-Ami et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Essential Oils, Silver Nanoparticles and Propolis as Alternative Agents Against Fluconazole Resistant Candida albicans, Candida glabrata and Candida krusei Clinical Isolates
- (2014) Piotr Szweda et al. INDIAN JOURNAL OF MICROBIOLOGY
- Silver nanoparticle production by the fungus Fusarium oxysporum: nanoparticle characterisation and analysis of antifungal activity against pathogenic yeasts
- (2014) Kelly Ishida et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations
- (2013) Barbara D. Alexander et al. CLINICAL INFECTIOUS DISEASES
- A study of the bactericidal, anti-biofouling, cytotoxic and antioxidant properties of actinobacterially synthesised silver nanoparticles
- (2013) Thangavel Shanmugasundaram et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- The emerging world of the fungal microbiome
- (2013) Gary B. Huffnagle et al. TRENDS IN MICROBIOLOGY
- Interactions between copy number and expression level of genes involved in fluconazole resistance in Candida glabrata
- (2013) Salma Abbes et al. Frontiers in Cellular and Infection Microbiology
- Biogenic antimicrobial silver nanoparticles produced by fungi
- (2012) Alexandre G. Rodrigues et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Occurrence, presentation and treatment of candidemia
- (2012) Małgorzata Mikulska et al. Expert Review of Clinical Immunology
- The cellular and molecular defense mechanisms of the Candida yeasts against azole antifungal drugs
- (2012) T. Noël JOURNAL DE MYCOLOGIE MEDICALE
- Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options
- (2012) J. C. O. Sardi et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Silver nanoparticles: influence of stabilizing agent and diameter on antifungal activity against Candida albicans and Candida glabrata biofilms
- (2012) D.R. Monteiro et al. LETTERS IN APPLIED MICROBIOLOGY
- Antifungal Susceptibility Profiles of 1698 Yeast Reference Strains Revealing Potential Emerging Human Pathogens
- (2012) Marie Desnos-Ollivier et al. PLoS One
- The Intervention of Nanotechnology Against Epithelial Fungal Diseases
- (2012) Leticia H. Higa et al. Journal of Biomaterials and Tissue Engineering
- “Nanoantibiotics”: A new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era
- (2011) Ae Jung Huh et al. JOURNAL OF CONTROLLED RELEASE
- Emerging opportunistic yeast infections
- (2011) Marisa H Miceli et al. LANCET INFECTIOUS DISEASES
- Current Concepts in Antifungal Pharmacology
- (2011) Russell E. Lewis MAYO CLINIC PROCEEDINGS
- Candida albicans interactions with epithelial cells and mucosal immunity
- (2011) Julian R. Naglik et al. MICROBES AND INFECTION
- Toxicological studies on silver nanoparticles: challenges and opportunities in assessment, monitoring and imaging
- (2011) Matthew Charles Stensberg et al. Nanomedicine
- Synthesis and antibacterial activity of silver nanoparticles against gram-positive and gram-negative bacteria
- (2011) Maribel Guzman et al. Nanomedicine-Nanotechnology Biology and Medicine
- CandidaBloodstream Infections: Comparison of Species Distributions and Antifungal Resistance Patterns in Community-Onset and Nosocomial Isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009
- (2010) Michael A. Pfaller et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synthesis and applications of silver nanoparticles
- (2010) Kholoud M.M. Abou El-Nour et al. Arabian Journal of Chemistry
- Antifungal activity of silver nanoparticles against Candida spp.
- (2009) Aleš Panáček et al. BIOMATERIALS
- Effect of macromolecule poly(vinyl alcohol) on the growth of cetyltrimethylammonium bromide stabilized Ag-nanoparticles
- (2009) Zaheer Khan et al. COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS
- Cytotoxicity and Immunological Response of Gold and Silver Nanoparticles of Different Sizes
- (2009) Hung-Jen Yen et al. Small
- Silver nanoparticles: Green synthesis and their antimicrobial activities
- (2008) Virender K. Sharma et al. ADVANCES IN COLLOID AND INTERFACE SCIENCE
- Silver nanoparticles as a new generation of antimicrobials
- (2008) Mahendra Rai et al. BIOTECHNOLOGY ADVANCES
- Colloidal silver solutions with antimicrobial properties
- (2008) A. Petica et al. Materials Science and Engineering B-Advanced Functional Solid-State Materials
- The inhibitory effects of silver nanoparticles, silver ions, and silver chloride colloids on microbial growth
- (2008) Okkyoung Choi et al. WATER RESEARCH
- Resistance to Antifungal Agents: Mechanisms and Clinical Impact
- (2007) Z. A. Kanafani et al. CLINICAL INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started